Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group (Q33358397)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group |
scientific article |
Statements
1 reference
Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group (English)
1 reference
1 reference
Howard Hochster
1 reference
Elizabeth R Plimack
1 reference
Carolyn D Runowicz
1 reference
James Speyer
1 reference
Robert C Wallach
1 reference
Joan Sorich
1 reference
John Mandeli
1 reference
Scott Wadler
1 reference
John Wright
1 reference
1 January 2004
1 reference
1 reference
22
1 reference
120-126
1 reference
Identifiers
1 reference
1 reference